MRMarlene Alejandra Rodriguez-Barragan

Marlene Alejandra Rodriguez-Barragan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marlene Alejandra Rodriguez-Barragan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning–Based Predictive Model for Functional Independence in Spinal Cord Injury: Protocol for a Predictive Rule Development and Validation Study

    by Alberto Isaac Perez-Sanpablo, Marlene Alejandra Rodriguez-Barragan, Alicia Meneses-Peñaloza, Jimena Quinzaños-Fresnedo, Aida Barrera-Ortiz, Fabiola Monserrat Palomino-Ramos, Oscar Prado-Escobar, Marcela D Rodríguez, Irvin Hussein Lopez-Nava, Jose Ambrosio-Bastian

    Background: Spinal cord injury (SCI) causes substantial disability by disrupting spinal pathways, making functional independence a central rehabilitation goal. In 2024, approximately 15.4 million people worldwide were living with SCI. Despite its clinical relevance, traditional prognostic tools, notably the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), have limitations. Furthermore, access to advanced diagnostics constrains prediction. Existing models often fail to estimate independence, limiting goal setting and resource planning. Objective: This study aims to develop and validate machine learning (ML)–based rules that predict functional independence, as measured by the Spinal Cord Independence Measure, version III (SCIM-III), at 3, 6, and 12 months post injury in individuals with SCI. The model combines clinical admission predictors, readily available to enhance predictive performance: age, sex, time since injury, upper and lower extremity strength, ISNCSCI data (American Spinal Injury Association Impairment Scale grade and neurologic level of injury), rehabilitation type, and the Trunk Control Scale score validated by the research team. Methods: Using retrospective electronic clinical records (2015‐2026) from Mexico’s Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra (INR LGII; a tertiary national rehabilitation reference center) for model development and a prospective independent cohort (October 2026-October 2027) for external validation, the study will develop ML models to accurately and generally predict SCIM-III outcomes. Eligible participants are adults (≥18 years of age) with subacute or chronic SCI. Six architectures are compared: linear regression, classification and regression tree, categorical boosting (gradient boosting algorithm), light gradient boosting machine, multilayer perceptron, and Gaussian process regression, using 10-fold stratified cross-validation for internal validation. Performance is assessed by root-mean-square error, mean absolute error, R ², area under the curve, calibration plots, and decision curve analysis. The approach prioritizes reproducibility, interpretability, and clinical applicability, addressing prior models’ limitations (small sample sizes, limited validation, and impractical input requirements). Key steps include data preprocessing, feature selection, model training with appropriate algorithms, and robust evaluation against existing prognostic benchmarks. External validation and ethical considerations are integrated, with commitments to data sharing where feasible. Results: The study was approved and funded in October 2025. The retrospective development cohort targets 500 registries (from 2025‐2026) collected between October 2025 and June 2026. A total of 119 records were processed by March 2026. ML development is planned between June 2026 and March 2027. The external prospective validation cohort (n=100) is planned for October 2026-October 2027, and validation for June 2027-March 2028. Results are expected by January 2028. Conclusions: A reliable, clinically actionable ML-based prediction tool that estimates SCIM-III trajectories to support goal setting, rehabilitation planning, and resource allocation in SCI care will be developed. Model performance will be benchmarked against published SCI prediction rules, and it will be considered clinically useful if it outperforms the mean-score baseline and existing rules on the prospective validation cohort.

  • Open Access

    Machine Learning-Based Predictive Model for Functional Independence in Spinal Cord Injury: Protocol for a Predictive Rule Development and Validation Study (Preprint)

    by Alberto Isaac Perez-Sanpablo, Marlene Alejandra Rodriguez-Barragan, Alicia Meneses-Pañaloza, Jimena Quinzanos Fresnedo, Aida Barrera-Ortiz, Fabiola Monserrat Palomino-Ramos, Oscar Prado-Escobar, Marcela D. Rodriguez-Urrea, Irvin Hussein Lopez-Nava, Jose Ambrosio-Bastian

    BACKGROUND : Spinal cord injury (SCI) causes substantial disability by disrupting spinal pathways, making functional independence a central rehabilitation goal. Traditional prognostic tools, notably the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), have limitations, including ceiling effects and misclassification during evaluation. Access to MRI, and neurophysiological measures is often restricted to specialized centers and early post-injury windows. Consequently, clinical prediction rules and conventional regression models—often focused on independent walking and less SCI-specific outcomes—may inadequately forecast overall independence, limiting goal setting and resource planning. OBJECTIVE To develop and validate machine learning (ML)-based rules that predict functional independence, as measured by SCIM-III, at 3, 6, and 12 months post-injury in individuals with SCI. The model combines clinical admission predictors, readily available to enhance predictive performance: age, sex, time since injury, upper and lower extremity strength (UEMS/LEMS), ISNCSCI data (ASIA Impairment Scale (AIS) grade and neurologic level of injury (NLI)), rehabilitation type and the trunk-control scale (ECT) score validated by the research team. METHODS Using retrospective electronic clinical records (2015–2026) from Mexico’s National Institute of Rehabilitation (INR LGII; a tertiary national rehabilitation reference center) for model development and a prospective independent cohort (January–December 2027) for external validation, the study will develop ML models to accurately and generally predict SCIM-III outcomes. Eligible participants are adults (≥18 years) with subacute or chronic SCI. Six architectures are compared: linear regression, CART, CatBoost, LightGBM, multilayer perceptron, and Gaussian process regression, using 10-fold stratified cross-validation for internal validation. Performance is assessed by RMSE, MAE, R², AUC, calibration plots, and decision curve analysis. The approach prioritizes reproducibility, interpretability, and clinical applicability, addressing prior models’ limitations (small sample sizes, limited validation, impractical input requirements). Key steps include data preprocessing, feature selection, model training with appropriate algorithms, and robust evaluation against existing prognostic benchmarks. External validation and ethical considerations are integrated, with commitments to data sharing where feasible. RESULTS The development cohort targets ≥500 retrospective records; the external validation cohort will prospectively register 100 records. Results will be reported upon study completion. CONCLUSIONS This protocol describes the first Mexican study to develop a validated ML-based prediction rule for functional independence (SCIM-III) in SCI rehabilitation. A reliable, clinically actionable ML-based prediction tool that estimates SCIM-III trajectories to support goal setting, rehabilitation planning, and resource allocation in SCI care will be developed. Model performance will be benchmarked against published SCI prediction rules, and it will be considered clinically useful if it outperforms the mean-score baseline and existing rules on the prospective validation cohort. CLINICALTRIAL This study (SECIHTI CBF-2025-I-3891, INRLGII 128/25) is embargoed preregistered on the Open Science Framework (OSF; URL: osf.io/4fmy6), and on the Mexican national clinical registry (estudiosclinicos.salud.gob.mx No: INRLGII 128/25). Both registrations are completed prior to prospective data collection.

  • Upper Limb Recovery in Cervical Spinal Cord Injury After a Brain-Computer Interface Controlled Functional Electrical Stimulation Intervention

    by Jessica Cantillo-Negrete, Ruben I. Carino-Escobar, Ismael Leyva-Martinez, Aida Barrera-Ortiz, Marlene A. Rodriguez-Barragan, Omar Mendoza-Montoya, Javier M. Antelis


  • Brain-computer interface as complementary therapy for hemiparesis in an astrocytoma patient

    by Ruben I. Carino-Escobar, Marlene A. Rodriguez-Barragan, Paul Carrillo-Mora, Jessica Cantillo-Negrete


  • Prognosis of stroke upper limb recovery with physiological variables using regression tree ensembles

    by Ruben I Carino-Escobar, Raquel Valdés-Cristerna, Paul Carrillo-Mora, Marlene A Rodriguez-Barragan, Claudia Hernandez-Arenas, Jimena Quinzaños-Fresnedo, Oscar Arias-Carrión, Jessica Cantillo-Negrete

    Objective. This study assesses upper limb recovery prognosis after stroke with solely physiological information, which can provide an objective estimation of recovery. Approach. Clinical recovery was forecasted using EEG-derived Event-Related Desynchronization/Synchronization and coherence, in addition to Transcranial Magnetic Stimulation elicited motor-evoked potentials and upper limb grip and pinch strength. A Regression Tree Ensemble predicted clinical recovery of a stroke database ( n = 10) measured after a two-month intervention with the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE) and the Action Research Arm Test (ARAT). Main results. There were no significant differences between predicted and actual outcomes with FMA-UE ( p = 0.29) and ARAT ( p = 0.5). Median prediction error for FMA-UE and ARAT were of 0.3 (IQR = 6.2) and 3.4 (IQR = 9.4) points, respectively. Predictions with the most pronounced errors were due to an underestimation of high upper limb recovery. The best features for FMA-UE prediction included mostly beta activity over the sensorimotor cortex. Best ARAT prediction features were cortical beta activity, corticospinal tract integrity of the unaffected hemisphere, and upper limb strength. Significance. Results highlighted the importance of measuring cortical activity related to motor control processes, the unaffected hemisphere’s integrity, and upper limb strength for prognosis. It was also implied that stroke upper limb recovery prediction is feasible using solely physiological variables with a Regression Tree Ensemble, which can also be used to analyze physiological relationships with recovery.


  • Frequency of intravenous thrombolysis in Mexican patients with acute ischemic stroke

    by Antonio Arauz, Beatriz Mendez, Eduardo Soriano-Navarro, Angélica Ruiz-Franco, Jimena Quinzaños, Marlene Rodríguez-Barragán, Erick García-Valadez, Fernando Góngora-Rivera


  • Open Access

    Longitudinal Analysis of Stroke Patients’ Brain Rhythms during an Intervention with a Brain-Computer Interface

    by Ruben I. Carino-Escobar, Paul Carrillo-Mora, Raquel Valdés-Cristerna, Marlene A. Rodriguez-Barragan, Claudia Hernandez-Arenas, Jimena Quinzaños-Fresnedo, Marlene A. Galicia-Alvarado, Jessica Cantillo-Negrete

    Stroke is a leading cause of motor disability worldwide. Upper limb rehabilitation is particularly challenging since approximately 35% of patients recover significant hand function after 6 months of the stroke’s onset. Therefore, new therapies, especially those based on brain-computer interfaces (BCI) and robotic assistive devices, are currently under research. Electroencephalography (EEG) acquired brain rhythms in alpha and beta bands, during motor tasks, such as motor imagery/intention (MI), could provide insight of motor-related neural plasticity occurring during a BCI intervention. Hence, a longitudinal analysis of subacute stroke patients’ brain rhythms during a BCI coupled to robotic device intervention was performed in this study. Data of 9 stroke patients were acquired across 12 sessions of the BCI intervention. Alpha and beta event-related desynchronization/synchronization (ERD/ERS) trends across sessions and their association with time since stroke onset and clinical upper extremity recovery were analyzed, using correlation and linear stepwise regression, respectively. More EEG channels presented significant ERD/ERS trends across sessions related with time since stroke onset, in beta, compared to alpha. Linear models implied a moderate relationship between alpha rhythms in frontal, temporal, and parietal areas with upper limb motor recovery and suggested a strong association between beta activity in frontal, central, and parietal regions with upper limb motor recovery. Higher association of beta with both time since stroke onset and upper limb motor recovery could be explained by beta relation with closed-loop communication between the sensorimotor cortex and the paralyzed upper limb, and alpha being probably more associated with motor learning mechanisms. The association between upper limb motor recovery and beta activations reinforces the hypothesis that broader regions of the cortex activate during movement tasks as a compensatory mechanism in stroke patients with severe motor impairment. Therefore, EEG across BCI interventions could provide valuable information for prognosis and BCI cortical activity targets.


  • Pharmacological Stimulation of Neuronal Plasticity in Acquired Brain Injury

    by Paul Carrillo-Mora, Juan Manuel Alcantar-Shramm, Kievka M. Almaguer-Benavides, Julio José Macías-Gallardo, Alim Fuentes-Bello, Marlene A. Rodríguez-Barragán

    Introduction: Brain injuries are one of the leading causes of disability worldwide. It is estimated that nearly half of patients who develop severe sequelae will continue with a chronic severe disability despite having received an appropriate rehabilitation program. For more than 3 decades, there has been a worldwide effort to investigate the possibility of pharmacologically stimulating the neuroplasticity process for enhancing the recovery of these patients. Objective: The objective of this article is to make a critical and updated review of the available evidence that supports the positive effect of different drugs on the recovery from brain injury. Method: To date, there have been several clinical trials that tested different drugs that act on different neurotransmitter systems: catecholaminergic, cholinergic, serotonergic, and glutamatergic. There is both basic and clinical evidence that may support some positive effect of these drugs on motor, cognitive, and language skills; however, only few of the available studies are of sufficient methodological quality (placebo controlled, randomized, blinded, multicenter, etc) to make solid conclusions about their beneficial effects. Conclusions: Currently, the pharmacological stimulation of neuroplasticity still does not have enough scientific evidence to make a systematic therapeutic recommendation for all patients, but it certainly is a feasible and very promising field for future research.